Background image representing scientific research

Attentive Science UAE - Abu Dhabi

Your Mission,
Our Research,
Healthier Outcomes.

Attentive Science is always working to improve and we have come a long way! Follow us as we evolve together.

Welcome, to UAE - Abu Dhabi

We're here for excellent services.

Your Mission, Our Research, Healthier Outcomes. At Attentive Science, we are committed to advancing non-clinical research that shapes the future of healthcare. From pioneering studies to everyday insights, we support your mission with precision, innovation, and a dedication to healthier outcomes. Join us on this journey as we evolve together to meet tomorrow's challenges, today. "Empowering Research, Inspiring Progress."

In-Vitro Services

Biomarker Evaluation

Biomarker Evaluation

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Flow Cytometry (FACS)

• Polymerase Chain Reaction (PCR)

• Western Blot

Genetic Toxicity

Genetic Toxicity

• Ames Test (OECD471)

• MicronucleusAssay (OECD 487)

• ChromosomeAberration Test(OECD 473)

Cell Based Assays

Cell Based Assays

• Cytotoxicity Assays

• Cell Culture

• Transfection

• Custom Assays

In-Vivo Pharmacology Services

Pharmcology

Pharmacology

  • Pharmacokinetics (HTS and TK)
  • Infectious disease models
  • Inflammation Models
  • Metabolism Models
  • Surgical Models
  • Xenograft Models
  • Other Disease Models

Why Choose Attentive Science UAE?

Strategic MENA Gateway

Abu Dhabi serves as your strategic entry point to Middle East and North Africa markets with excellent connectivity and business infrastructure

Regional Regulatory Knowledge

Deep understanding of UAE MOH, Dubai DHA, and GCC regulatory frameworks ensuring smooth approval processes

Cultural & Market Expertise

Team experienced in Global as well as Middle Eastern pharmaceutical market dynamics and cultural considerations for clinical development

Regional Research Network

Strategic collaborations with local research institutions, hospitals, and Key Opinion Leaders across the MENA region

Metabolic Disease Specialization

Specialized capabilities in diabetes, obesity, and metabolic syndrome research relevant to regional health priorities

Abu Dhabi State-of-the-Art Research Facility

Modern preclinical research infrastructure designed for the Middle Eastern environment and Global research needs

• BSL-2 certified laboratories for infectious disease and vaccine research
• Advanced molecular biology suite with real-time PCR, flow cytometry, and cell culture facilities
• Dedicated vivarium with climate control optimized for regional environmental conditions all year round
• Species housing capacity for rodents, rabbits, and specialized models
• On-site pathology and histology processing laboratory
• Specialized metabolic disease research capabilities including metabolic cage studies
• In-vitro testing capabilities for ELISA, Western blot, and genetic toxicity
• Modern surgical facilities for pharmacology studies
• Electronic study management systems for data integrity
• Dedicated areas for test article storage and formulation preparation
• Regular equipment maintenance and calibration programs
• Backup systems ensuring environmental stability

Meet Our Management Team

Namir Shaabani

Namir Shaabani
PhD, Bpharm

Co-Founder & CSO

With over 15 years of experience in research and development, Dr. Shaabani has a proven track record in early-stage drug development, guiding projects from target identification to Investigational New Drug (IND) applications. A holder of multiple intellectual property (IP) rights, Namir earned a PhD in Immunology from the University of Heinrich Heine Düsseldorf

Tareq Abunadi

Tareq Abunadi
Bsc

Co-Founder & CEO

With over 21 years of industry experience, Tareq has worked with renowned organizations such as Covance (Labcorp), OSI Pharmaceuticals, Bolder BioPath, BTS Research, and Attentive Science Kansas. Tareq holds a BSc in Applied Biology from the Jordan University of Science and Technology, bringing extensive expertise to the field

What Our Clients Say

"The level of service, capabilities, and knowledge received were outstanding. Attentive Science demonstrated exceptional scientific rigor and responsive communication throughout our collaboration."

Kyle Abuarjah

CEO

BioPulse Consulting

"Big shout-outs to the Study Director and all the great staff for executing such a complex study. The GLP audit went flawlessly and the quality of data exceeded our expectations."

Chief Scientific Officer

Chief Scientific Officer

Neuroscience-focused biotech company, USA